Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Erika K, Pollex"'
Autor:
Erika K. Pollex, Janine R. Hutson
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 7:325-339
The prevalence of diabetes among women of childbearing age is increasing. This will inevitably increase the number of pregnancies complicated by diabetes. The management of diabetes mellitus often necessitates the use of oral antidiabetic drugs inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4861dc0c1031452d890761ba12d11f
https://doi.org/10.1517/17425255.2011.553188
https://doi.org/10.1517/17425255.2011.553188
Publikováno v:
Annals of Pharmacotherapy. 45:9-16
Background The prevalence of diabetes in women of childbearing age is increasing. As such, the number of pregnancies complicated by diabetes will inevitably increase. New insulin analogues such as the long-acting analogue Insulin glargine may represe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03e5a5b04f08209e0a6304f4a961b4f4
https://doi.org/10.1345/aph.1p327
https://doi.org/10.1345/aph.1p327
Publikováno v:
Drug Metabolism and Disposition. 38:740-744
The antidiabetic agent glyburide (glibenclamide) is frequently used for the treatment of type II diabetes and is increasingly being used for the treatment of gestational diabetes. Evidence suggests that breast cancer resistance protein/ATP-binding ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::647ee18d2d93548ae6b363f0a4221ac4
https://doi.org/10.1124/dmd.109.030791
https://doi.org/10.1124/dmd.109.030791
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 23:224-228
The current trend towards an increase in the rate of Type 2 diabetes in women of childbearing age will inevitably result in an increasing number of women requiring hypoglycemic therapy throughout pregnancy. For patients with Type 2 diabetes or gestat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec54c4d9ac91c65b9f72b86d794912a
https://doi.org/10.3109/14767050903550881
https://doi.org/10.3109/14767050903550881
Publikováno v:
Diabetes Care. 33:29-33
OBJECTIVE Insulin glargine (Lantus) is an extended-action insulin analog with greater stability and duration of action than regular human insulin. The long duration of action and decreased incidence of hypoglycemia provide potential advantages for it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e51d5fc058747a7b2a8ce76f663a7d7
https://doi.org/10.2337/dc09-1045
https://doi.org/10.2337/dc09-1045
Publikováno v:
Placenta. 29:743-747
Gestational diabetes mellitus is a common medical complication in pregnancy. Recent findings demonstrate that glyburide is effluxed against a concentration gradient from the fetal to the maternal circulation. However, the transport systems involved i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5970068652486751614bf9a5c7069f
https://doi.org/10.1016/j.placenta.2008.05.001
https://doi.org/10.1016/j.placenta.2008.05.001
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 21:191-196
The purpose of this review is to provide a brief overview of the safety of antidiabetics in pregnancy. Specifically, concerns over teratogenicity due to the possible placental transfer of antidiabetics as well as maternal and neonatal outcomes are ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::026bb33cb46033c93b2d1b1d3a2a6d2b
https://doi.org/10.1080/14767050801929653
https://doi.org/10.1080/14767050801929653
Publikováno v:
Diabetes Care
OBJECTIVE Insulin glargine (Lantus) is an extended-action insulin analog with greater stability and duration of action than regular human insulin. The long duration of action and decreased incidence of hypoglycemia provide potential advantages for it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aadb79da08d4c31384bc87a05e76258b
https://pubmed.ncbi.nlm.nih.gov/19808914
https://pubmed.ncbi.nlm.nih.gov/19808914
Publikováno v:
Therapeutic drug monitoring. 31(5)
A wide range of physiological and hormonal changes occur during pregnancy. Most begin early in the first trimester and increase by the last trimester. These changes can significantly affect pharmacokinetics and pharmacodynamics of drugs and thus may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c508a549b2655536492603117a51b86
https://pubmed.ncbi.nlm.nih.gov/19730277
https://pubmed.ncbi.nlm.nih.gov/19730277
Publikováno v:
Reproductive Toxicology. 31:250-250
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb7780f50956b2e67d7bf768bf7e426
https://doi.org/10.1016/j.reprotox.2010.12.063
https://doi.org/10.1016/j.reprotox.2010.12.063